麻豆传媒

Trusted by:

clients clients clients clients clients clients clients clients clients clients
Released: 25-Mar-1999 12:00 AM EST
Consumers Raise Concerns about Possible Link Between Chronic Heartburn and Esophageal Cancer
American College of Gastroenterology (ACG)

The American College of Gastroenterology (ACG) commissioned a flash poll of gastroenterologists and found a marked increase in patients calling their doctors to inquire about the possible links between heartburn and cancer.

18-Oct-1999 12:00 AM EDT
Athletes at Greater Risk for Heartburn and GI Problems
American College of Gastroenterology (ACG)

Athletes who compete in a variety of sports are more likely to experience gastrointestinal distress and heartburn than the general population, according to a recent study conducted by the Oklahoma Foundation for Digestive Research and the University of Oklahoma Department of Health and Sport Sciences and released at the American College of Gastroenterology annual meeting.

18-Oct-1999 12:00 AM EDT
Colonoscopy, Most Complete Cancer Screening
American College of Gastroenterology (ACG)

Screening exams that allow physicians to visualize the entire colon are more likely to detect lesions than flexible sigmoidoscopy, which examines only the lower one-third of the colon, according to a study presented at the American College of Gastroenterology annual meeting.

18-Oct-1999 12:00 AM EDT
Colon Cancer Screening Costs Compare Favorably with Other Screening Tests
American College of Gastroenterology (ACG)

Colonoscopy screening is a cost-effective strategy for preventing colorectal cancer and increasing life expectancy among average risk patients over 50 in a managed care setting according to findings from a recent Duke University Medical Center study presented at the American College of Gastroenterology annual meeting.

18-Oct-1999 12:00 AM EDT
COX-2 Inhibitors Reduce Risk of Colon Cancer
American College of Gastroenterology (ACG)

Celecoxib, a COX-2 inhibitor, is effective in reducing colorectal polyps in patients with an inherited condition known as familial adenomatous polyposis or FAP, according to a study presented at the American College of Gastroenterology annual meeting.

18-Oct-1999 12:00 AM EDT
Race not a Factor in Gastroesophageal Reflux Disease (GERD)
American College of Gastroenterology (ACG)

Gastroesophageal reflux disease (GERD) does not discriminate between races, affecting blacks and whites equally, according to a study presented today at the 64th Annual Scientific Meeting of the American College of Gastroenterology (ACG).

18-Oct-1999 12:00 AM EDT
Yogurt May Help Prevent Diarrhea from Antibiotic Use
American College of Gastroenterology (ACG)

Yogurt may help reduce or prevent antibiotic associated diarrhea, the most common side effect associated with antibiotic treatment, according to a study presented at the American College of Gastroenterology annual meeting.

18-Oct-1999 12:00 AM EDT
Gastrointestinal Benefits of COX-2 Inhibitors
American College of Gastroenterology (ACG)

A new class of prescription-strength pain relievers, referred to as COX-2 inhibitors, appears to reduce adverse gastrointestinal effects, while retaining pain relief and anti-inflammatory qualities, according to several papers presented at the meeting of the American College of Gastroenterology in Phoenix, October 18-20. The studies confirm and quantify the reduction in GI side effects for some of these new pharmacologic agents.

18-Oct-1999 12:00 AM EDT
H. Pylori in Duodenal Ulcer Diminishes with NSAID Use
American College of Gastroenterology (ACG)

A prospective study of the incidence of Helicobacter pylori infection in duodenal ulcer patients found that infection with this bacterium once implicated in over 90% of ulcers was present in only 55% of patients presenting with ulcers, researchers reported at the American College of Gastroenterology annual meeting.

18-Oct-1999 12:00 AM EDT
New Treatments for Irritable Bowel Syndrome
American College of Gastroenterology (ACG)

Three separate studies being presented at the Annual Meeting of the American College of Gastroenterology, underscore a promising new class of medication that may offer symptom relief and improved outcomes for patients with irritable bowel syndrome (IBS) or chronic constipation. The three studies, which report positive results with three separate agents for treatment of either IBS or chronic constipation, will offer new therapeutic alternatives for patients.


close
1.59175